Antix Holdings, Revenue Growth Rates (IMTH), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
AnTix Holdings, Inc.  (IMTH)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

IMTH's Revenue Growth by Quarter and Year

Antix Holdings,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMTH Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter June 0.00
3rd Quarter March 0.00
2nd Quarter December 0.00
1st Quarter September 0.43
FY 0.43





IMTH Revenue fourth quarter 2025 Y/Y Growth Comment
AnTix Holdings, Inc. in the fourth quarter 2025 recorded of $ 0.00 millions.

According to the results reported in the fourth quarter 2025, Antix Holdings, Inc. achieved the best Revenue growth in Healthcare Facilities industry. While Antix Holdings, Inc.' s Revenue meltdown of -100% ranks overall at the positon no. in the fourth quarter 2025.


IMTH Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter June - 4.55 % 22.22 % 28.57 %
3rd Quarter March - -4.17 % 65.52 % 314.29 %
2nd Quarter December - 2.38 % 27.27 % -
1st Quarter September -10.42 % 26.32 % 18.75 % -
FY   -76.5 % 6.4 % 32.31 % -

Financial Statements
Antix Holdings,'s fourth quarter 2025 Revenue $ 0.00 millions IMTH's Income Statement
Antix Holdings,'s fourth quarter 2024 Revenue $ 0.46 millions Quarterly IMTH's Income Statement


IMTH Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter June - 0 % -8.33 % 24.14 %
3rd Quarter March - 6.98 % 14.29 % -12.12 %
2nd Quarter December - -10.42 % 10.53 % 3.13 %
1st Quarter September -6.52 % 9.09 % 5.56 % 14.29 %
FY (Year on Year)   -76.5 % 6.4 % 32.31 % -


Back to IMTH Growth rate Comparisons >> Back to IMTH Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
(Dec 31 2022)   (Sep 30 2024)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
(Dec 31 2022)   (Sep 30 2024)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Antix Holdings,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMTH's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMTH's IV. Quarter Q/Q Revenue Comment


Antix Holdings,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 1.77 $ 1.82
Y / Y Revenue Growth (TTM) - - - -2.68 % 5.8 %
Year on Year Revenue Growth Overall Ranking # # # # 2588 # 1652
Seqeuential Revenue Change (TTM) - - - -2.87 % 0.72 %
Seq. Revenue Growth (TTM) Overall Ranking # # # # 2588 # 1652


Cumulative Revenue growth Comment
Antix Holdings, Inc. realized trailing twelve months of $ 0 millions, in the Jun 30 2025, compare to Revenue of $ 2 millions a year ago.

AnTix Holdings, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
46 %
 23.34 %
-2.68 %
(Dec 31 2022)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0
Cumulative Revenue growth Comment
Antix Holdings, Inc. realized trailing twelve months of $ 0 millions, in the Jun 30 2025, compare to Revenue of $ 2 millions a year ago.

AnTix Holdings, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
46 %
23.34 %
-2.68 %
(Dec 31 2022)  






Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
IMTH's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue meltdown for the quarter ending Jun 30 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2025
Carlisle Companies Incorporated-0.08%$ -0.076 millions
Zimvie Inc -0.13%$ -0.128 millions
Community Health Systems Inc -0.22%$ -0.223 millions
Bruker Corporation-0.46%$ -0.462 millions
Integra Lifesciences Holdings Corp-0.61%$ -0.615 millions
Adapthealth Corp -0.70%$ -0.695 millions
Perrigo Company Plc-0.79%$ -0.789 millions
Organon and Co -0.81%$ -0.809 millions
Castle Biosciences Inc -0.94%$ -0.936 millions
Vaso Corporation-0.96%$ -0.963 millions
Profound Medical Corp -0.99%$ -0.985 millions
Capsovision Inc -1.13%$ -1.126 millions
Avantor Inc -1.14%$ -1.139 millions
Inspiremd Inc -1.35%$ -1.352 millions
Align Technology inc -1.51%$ -1.509 millions
Teladoc Health Inc -1.64%$ -1.641 millions
Supernus Pharmaceuticals inc -1.71%$ -1.706 millions
Encision Inc -1.73%$ -1.729 millions
Cytek Biosciences Inc -1.80%$ -1.796 millions
Merck and Co Inc -1.90%$ -1.899 millions
Bioventus Inc -1.98%$ -1.978 millions
Alkermes Plc -2.12%$ -2.123 millions
Anteris Technologies Global Corp -2.22%$ -2.215 millions
Surmodics Inc -2.55%$ -2.551 millions
Nrc Health-2.81%$ -2.807 millions
Rxsight Inc -3.09%$ -3.095 millions
Apyx Medical Corp-3.57%$ -3.567 millions
Quidelortho Corp-3.63%$ -3.626 millions
Lantheus Holdings Inc -4.00%$ -4.003 millions
Quipt Home Medical Corp -4.07%$ -4.065 millions


About Antix Holdings, Revenue Growth Rates (IMTH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Antix Holdings Inc (CIK 1331612).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001477932-26-000103
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Antix Holdings Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.